Biodexa Completes Recruitment of Cohort A in Study of MTX110 in Patients with Recurrent Glioblastoma
03 oct. 2023 08h30 HE
|
Biodexa Pharmaceuticals PLC
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Completes Recruitment of Cohort A in Study of MTX110 in Patients with Recurrent Glioblastoma Biodexa Pharmaceuticals PLC, (Nasdaq:...
Syneos Health Appoints Colin Shannon as Chief Executive Officer
03 oct. 2023 08h00 HE
|
Syneos Health, Inc.
Syneos Health today appointed Collin Shannon as its new CEO. Michelle Keefe remains on Company Board and member of its executive leadership team.
Interim results for the six months ended 30 June 2023
29 sept. 2023 16h30 HE
|
Biodexa Pharmaceuticals PLC
29 September 2023 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Interim results for the six months ended 30 June 2023 Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a clinical stage...
[Latest] Global 3D Printed Medical Implant Market Size/Share Worth USD 9,099.9 Million by 2032 at a 19.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
21 sept. 2023 17h30 HE
|
Custom Market Insights
Austin, TX, USA, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “3D Printed Medical Implant Market Size, Trends and Insights By Component...
Biodexa to Present Recruitment and Treatment Update in Phase 1 Study of MTX-110 (MAGIC-G1 Study) in Patients with Recurrent Glioblastoma at 2023 Annual European Association of Neuro-Oncology Meeting (EANO)
21 sept. 2023 08h30 HE
|
Biodexa Pharmaceuticals PLC
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa to Present Recruitment and Treatment Update in Phase 1 Study of MTX-110 (MAGIC-G1 Study) in Patients with Recurrent Glioblastoma at...
Scinai Immunotherapeutics Announces $1.33 Million Registered Direct Offering
15 sept. 2023 09h01 HE
|
Scinai Immunotherapeutics Ltd.
JERUSALEM, Sept. 15, 2023 (GLOBE NEWSWIRE) -- via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative...
Mammalian Transient Protein Expression Market revenue to exceed USD 650 Million by 2033, says Research Nester
14 sept. 2023 05h00 HE
|
Research Nester
New York, Sept. 14, 2023 (GLOBE NEWSWIRE) -- The global mammalian transient protein expression market size is expected to expand at ~8% CAGR from 2023 to 2033. The market is anticipated to garner a...
US Capital Global Engaged by PlantForm Corporation as Strategic Advisor on $25 Million Capital Formation
31 août 2023 07h35 HE
|
US Capital Global
San Francisco, California, USA, Aug. 31, 2023 (GLOBE NEWSWIRE) -- US Capital Global has been engaged by PlantForm Corporation (“PlantForm” or the “Company”) as its strategic financial advisor on a...
Microplate Washer Market Size to Hit USD 700 million by 2030, Expanding at a CAGR of 3% Says, Transparency Market Research
28 août 2023 06h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global microplate washer market is projected to flourish at a CAGR of 3% from 2019 to...
PaxMedica Appoints David Hough M.D. as Chief Medical Officer
16 août 2023 08h30 HE
|
PaxMedica, Inc.
Announces Additional Management Changes; Independent Directors Now Majority of Board TARRYTOWN, NY, Aug. 16, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – PaxMedica, Inc. (Nasdaq: PXMD), a clinical...